Jeremy Jenkins is the US Head of Discovery Sciences in Novartis Biomedical Research. He joined Novartis as a postdoc in 2003, following a postdoc at Harvard Medical School and a PhD in Molecular Genetics from The Ohio State University. He received the 2011 Corwin Hansch Award for contributions to the field of QSAR, and the 2017 Novartis Leading Scientist VIVA award for helping to develop the field of in silico chemical biology. His global research teams at Novartis focus on early drug discovery projects and enabling technologies for target ID and lead discovery.